Logo image of ZOMD.CA

ZOOMD TECHNOLOGIES LTD (ZOMD.CA) Stock Fundamental Analysis

TSX-V:ZOMD - TSX Venture Exchange - CA98981L1004 - Common Stock - Currency: CAD

0.79  -0.03 (-3.66%)

Fundamental Rating

6

ZOMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Software industry. ZOMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ZOMD has a correct valuation and a medium growth rate. These ratings would make ZOMD suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ZOMD had positive earnings in the past year.
ZOMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZOMD reported negative net income in multiple years.
ZOMD had a positive operating cash flow in 4 of the past 5 years.
ZOMD.CA Yearly Net Income VS EBIT VS OCF VS FCFZOMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

ZOMD's Return On Assets of 31.09% is amongst the best of the industry. ZOMD outperforms 96.83% of its industry peers.
ZOMD has a better Return On Equity (50.32%) than 95.24% of its industry peers.
ZOMD has a better Return On Invested Capital (31.40%) than 96.83% of its industry peers.
Industry RankSector Rank
ROA 31.09%
ROE 50.32%
ROIC 31.4%
ROA(3y)-1.77%
ROA(5y)-5.05%
ROE(3y)-8.35%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ZOMD.CA Yearly ROA, ROE, ROICZOMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

The Profit Margin of ZOMD (16.35%) is better than 87.30% of its industry peers.
ZOMD's Profit Margin has improved in the last couple of years.
ZOMD's Operating Margin of 16.95% is amongst the best of the industry. ZOMD outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of ZOMD has grown nicely.
The Gross Margin of ZOMD (39.46%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ZOMD has grown nicely.
Industry RankSector Rank
OM 16.95%
PM (TTM) 16.35%
GM 39.46%
OM growth 3Y43.69%
OM growth 5YN/A
PM growth 3Y50.97%
PM growth 5YN/A
GM growth 3Y8.4%
GM growth 5Y6.08%
ZOMD.CA Yearly Profit, Operating, Gross MarginsZOMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

ZOMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ZOMD has been increased compared to 1 year ago.
ZOMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ZOMD has been reduced compared to a year ago.
ZOMD.CA Yearly Shares OutstandingZOMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ZOMD.CA Yearly Total Debt VS Total AssetsZOMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

ZOMD has an Altman-Z score of 5.40. This indicates that ZOMD is financially healthy and has little risk of bankruptcy at the moment.
ZOMD has a Altman-Z score of 5.40. This is in the better half of the industry: ZOMD outperforms 77.78% of its industry peers.
The Debt to FCF ratio of ZOMD is 0.47, which is an excellent value as it means it would take ZOMD, only 0.47 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ZOMD (0.47) is better than 85.71% of its industry peers.
ZOMD has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
ZOMD's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. ZOMD outperforms 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 0.47
Altman-Z 5.4
ROIC/WACC3.38
WACC9.3%
ZOMD.CA Yearly LT Debt VS Equity VS FCFZOMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.09 indicates that ZOMD has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.09, ZOMD is doing good in the industry, outperforming 71.43% of the companies in the same industry.
ZOMD has a Quick Ratio of 2.09. This indicates that ZOMD is financially healthy and has no problem in meeting its short term obligations.
ZOMD's Quick ratio of 2.09 is fine compared to the rest of the industry. ZOMD outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
ZOMD.CA Yearly Current Assets VS Current LiabilitesZOMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 286.52% over the past year.
Measured over the past years, ZOMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.73% on average per year.
ZOMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.70%.
ZOMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.04% yearly.
EPS 1Y (TTM)286.52%
EPS 3Y50.73%
EPS 5YN/A
EPS Q2Q%9066.67%
Revenue 1Y (TTM)69.7%
Revenue growth 3Y1.2%
Revenue growth 5Y15.04%
Sales Q2Q%100.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZOMD.CA Yearly Revenue VS EstimatesZOMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.58, the valuation of ZOMD can be described as very cheap.
Based on the Price/Earnings ratio, ZOMD is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
ZOMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 6.58
Fwd PE N/A
ZOMD.CA Price Earnings VS Forward Price EarningsZOMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZOMD is valued cheaper than 92.06% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZOMD is valued cheaply inside the industry as 92.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.37
EV/EBITDA 4.3
ZOMD.CA Per share dataZOMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

The decent profitability rating of ZOMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZOMD!.
Industry RankSector Rank
Dividend Yield N/A

ZOOMD TECHNOLOGIES LTD

TSX-V:ZOMD (5/13/2025, 7:00:00 PM)

0.79

-0.03 (-3.66%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners22.15%
Ins Owner ChangeN/A
Market Cap78.34M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.58
Fwd PE N/A
P/S 1.03
P/FCF 7.37
P/OCF 7.28
P/B 3.16
P/tB 5.21
EV/EBITDA 4.3
EPS(TTM)0.12
EY15.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY13.57%
OCF(TTM)0.11
OCFY13.73%
SpS0.77
BVpS0.25
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 31.09%
ROE 50.32%
ROCE 48.16%
ROIC 31.4%
ROICexc 55.67%
ROICexgc 133.46%
OM 16.95%
PM (TTM) 16.35%
GM 39.46%
FCFM 13.94%
ROA(3y)-1.77%
ROA(5y)-5.05%
ROE(3y)-8.35%
ROE(5y)-10.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-15.12%
ROICexcg growth 5YN/A
ROICexc growth 3Y46.93%
ROICexc growth 5YN/A
OM growth 3Y43.69%
OM growth 5YN/A
PM growth 3Y50.97%
PM growth 5YN/A
GM growth 3Y8.4%
GM growth 5Y6.08%
F-Score7
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 0.47
Debt/EBITDA 0.3
Cap/Depr 4.5%
Cap/Sales 0.17%
Interest Coverage 70.5
Cash Conversion 68.39%
Profit Quality 85.25%
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z 5.4
F-Score7
WACC9.3%
ROIC/WACC3.38
Cap/Depr(3y)4.45%
Cap/Depr(5y)3.09%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)286.52%
EPS 3Y50.73%
EPS 5YN/A
EPS Q2Q%9066.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)69.7%
Revenue growth 3Y1.2%
Revenue growth 5Y15.04%
Sales Q2Q%100.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y836.44%
EBIT growth 3Y45.4%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1738.74%
FCF growth 3Y26.03%
FCF growth 5YN/A
OCF growth 1Y1695.33%
OCF growth 3Y26.18%
OCF growth 5YN/A